S&P Futures
4,208.25-38.25(-0.90%)Dow Futures
33,952.00-336.00(-0.98%)Nasdaq Futures
13,867.75-162.50(-1.16%)
Taysha Gene Therapies, Inc. (TSHA)
After hours: 04:00PM EDT
Chart Events
Performance Outlook
| Previous Close | 25.98 |
| Open | 25.66 |
| Bid | 24.44 x 800 |
| Ask | 24.65 x 800 |
| Day's Range | 24.26 - 26.15 |
| 52 Week Range | 18.16 - 33.35 |
| Volume | 117,465 |
| Avg. Volume | 129,495 |
| Market Cap | 945.052M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Mar 03, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 43.94 |
- Business Wire
Taysha Gene Therapies to Participate in Upcoming Investor Healthcare Conference and CEO Forum
DALLAS, Jun 15, 2021--Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in virtual fireside chats at the LifeSci Genetics Medicine Conference and LSX Biotech Growth CEO Forum.
- Business Wire
Taysha Gene Therapies to Host First Annual Stockholder Meeting
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its first annual stockholder meeting will be held June 17, 2021 at 10 am ET via webcast.
- Business Wire
Taysha Gene Therapies to Participate in Upcoming June Investor Healthcare Conferences
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivitol-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in a virtual fireside chat for the Jefferies Virtual Healthcare Conference, Goldman Sachs 42nd Annual Global Healthcare Conference, and the JMP Securities Life Science Conference.
